Metabolically Activated Proteostasis Regulators Reduce Differentiation of CD4+ TH17 Cells
Priyadarshini ChatterjeeiD, Keishla Sánchez OrtiziD, Stanislav DikiyiD, Michael J. BollongiD, Jessica E. ThaxtoniD, Alejandra MendozaiD, R. Luke WisemaniD
Abstract
The differentiation of naive CD4+ T cells into effector T cell subsets such as TH1, TH2, TH17 and TREG cells is governed by tightly coordinated activation programmes dependent on T cell receptor (TCR) engagement, co-stimulation, and cytokine signalling. This differentiation process involves regulation of stress-responsive signalling pathways such as the unfolded protein response (UPR) and the oxidative stress response (OSR) to adapt to the physiologic demands specific to distinct T cell subset functions. This suggests that pharmacologically targeting stress-responsive pathways offers a unique opportunity to selectively remodel the differentiation of these different T cell subsets. We previously identified compound AA147 as a metabolically activated proteostasis regulator that can induce both the ATF6 signalling arm of the UPR and, in certain cell types, the NRF2-regulated arm of the OSR. (Paxman et al., 2018; Plate et al., 2016) Here, we show that treatment with AA147 selectively reduces differentiation of pro-inflammatory TH17 cells by promoting degradation of the lineage-specifying transcription factor RORgammat, without impacting the transcription factors of other CD4+ T cell subsets. AA147-dependent reduction in TH17 differentiation is independent of ATF6 activation and involves activation of NRF2, which reduces intracellular reactive oxygen species (ROS) to hinder TH17 cell differentiation. Apart from RORgammat, we found that AA147 decreases expression of the TCR-responsive factor IRF4, thus suppressing production of select effector cytokines across effector T cells, demonstrating additional ways in which this compound reshapes the activities of these essential T cell subsets. Our results demonstrate the potential for metabolically activated proteostasis regulators such as AA147 to selectively reshape TH17 cell identity while broadly dampening effector cytokine responses across effector T cell subsets, through both NRF2-dependent and independent mechanisms during T cell differentiation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism
A. P. Cribbs, S. Terlecki-Zaniewicz, … U. Oppermann·bioRxiv·Oct 30, 2019
- ITK signaling regulates a switch between T helper 17 and T regulatory cell lineages via a calcium-mediated pathway
O. Anannya, W. Huang, A. August·bioRxiv·Apr 1, 2023
- P2X7 receptor signaling is not required but can enhance Th17 differentiation.
Y. Yang, M. E. Killeen, … A. R. Mathers·bioRxiv·Mar 19, 2021
- The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function
Y. Subbannayya, M. Haug, … R. K. Kandasamy·bioRxiv·Nov 17, 2020
- Engineered Th17 cell differentiation using a photo-activatable immune modulator
B. Parasar, P. V. Chang·bioRxiv·Jul 30, 2019
- Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
S. A. Saenz, A. Local, … J. M. Ellis·bioRxiv·Feb 19, 2021